{"title":"新产品介绍:苯培多酸/依折替米贝(新组合)、布来维肽、多酸铜铜64、达普达司他、地西他滨/西达脲(新组合)、盐酸芬氟拉明、醋酸吲达卡特罗/溴化甘溴铵/糠酸莫米松(新组合)、丝裂霉素C(新配方)、奥克特","authors":"","doi":"10.1358/dot.2020.56.10.3227672","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"52 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New product intros [bempedoic acid/ezetimibe (new combination), bulevirtide, copper Cu 64 dotatate, daprodustat, decitabine/cedazuridine (new combination), fenfluramine hydrochloride, indacaterol acetate/glycopyrronium bromide/mometasone furoate (new combination), mitomycin C (new formulation), octr\",\"authors\":\"\",\"doi\":\"10.1358/dot.2020.56.10.3227672\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":85144,\"journal\":{\"name\":\"Medicamentos de actualidad. Drugs of today\",\"volume\":\"52 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicamentos de actualidad. Drugs of today\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1358/dot.2020.56.10.3227672\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicamentos de actualidad. Drugs of today","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1358/dot.2020.56.10.3227672","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
New product intros [bempedoic acid/ezetimibe (new combination), bulevirtide, copper Cu 64 dotatate, daprodustat, decitabine/cedazuridine (new combination), fenfluramine hydrochloride, indacaterol acetate/glycopyrronium bromide/mometasone furoate (new combination), mitomycin C (new formulation), octr